AI’s Impact on Drug Development: Opportunities for Pharmaceutical Leaders
Claire Aldridge, PhD
Explore the transformative impact of artificial intelligence on drug development and its role in the future of pharmaceutical innovation
Drug Development
Novel Drug Improves Rare Kidney Disorder in Phase 3 Trial
University of Minnesota Medical School
Some 42 percent of patients treated with sparsentan showed reduced proteinuria
FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases
U.S. Food and Drug Administration
Wezlana has similar safety and efficacy as its reference product and is a cost-effective alternative for chronic inflammation
Antibody-Drug Conjugate Benefits HER2-Low Breast Cancers
German Institute for Quality and Efficiency in Health Care (IQWiG)
Patients with HER2-low breast cancers were included in the clinical trial proving the efficacy of trastuzumab deruxtecan monotherapy
FDA Approves Steroid-Like Drug for Duchenne Muscular Dystrophy
Children's National Hospital
Vamorolone offers a new treatment option with fewer side effects
Encaleret Restores Parathyroid Function in ADH1 Trial
Swathi Kodaikal, MSc
Some 3.9 in 100,000 people in the US are affected by ADH1, a major cause of nonsurgical hypoparathyroidism
Bispecific Cancer Drug Performs Well in Early Clinical Trial
University of Pittsburgh
Tebotelimab targets two proteins on tumor cells and drives specific immune response safely and effectively
Single-Arm Trials May Not Be Effective in Drug Development
German Institute for Quality and Efficiency in Health Care (IQWiG)
Experts urge EMA to prioritize evidence-based drug development over accelerated marketing authorization
FDA Approves First Biosimilar to Treat Multiple Sclerosis
U.S. Food and Drug Administration
Tyruko® has been shown to safely mitigate and manage inflammation in autoimmune conditions like Crohn’s disease
New Prostate Cancer Drug Shows Promise against COVID-19
Michigan Medicine - University of Michigan
Researchers look into a drug called proxalutamide as a potential therapeutic for the coronavirus